Arrowhead Pharmaceuticals, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2012 | — | $10.0M | $3.4M |
| FY2013 | — | $27.5M | $19.1M |
| FY2014 | — | $166.5M | $132.5M |
| FY2015 | — | $110.2M | $81.2M |
| FY2016 | — | $95.6M | $85.4M |
| FY2017 | — | $81.4M | $24.8M |
| FY2018 | — | $95.8M | $30.1M |
| FY2019 | — | $244.6M | $221.8M |
| FY2020 | — | $461.8M | $143.6M |
| FY2021 | — | $408.8M | $184.4M |